| Market Cap | 54.72M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | 8.8M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -10.00% |
| Sales | 58.98M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -50.00% |
| Dividend | N/A | Price/Book | 0.16 | EPS next 5Y | - | 52W High Chg | -82.00% |
| Recommedations | - | Quick Ratio | 0.53 | Shares Outstanding | 3.44B | 52W Low Chg | 3.00% |
| Insider Own | - | ROA | -1.46% | Shares Float | 3.38B | Beta | 1.07 |
| Inst Own | 0.00% | ROE | 12.06% | Shares Shorted/Prior | -/- | Price | 0.00310 |
| Gross Margin | 78.81% | Profit Margin | 14.91% | Avg. Volume | 4,225,361 | Target Price | - |
| Oper. Margin | -12.28% | Earnings Date | May 20 | Volume | 3,658,339 | Change | -3.12% |
Medical Marijuana, Inc., an investment holding company, operates in the cannabinoid-based nutraceutical industry. It focuses on the development, sale, and distribution of hemp oil that contains naturally occurring cannabinoids, including cannabidiol (CBD) and other products containing CBD-rich hemp oil; treatment of pain and other medical disorders with the application of chewing gum-based cannabis/cannabinoid medical products; and nonpsychoactive cannabidiol products. The company is also involved in the research and development of new therapeutic agents that are designed to reduce oxidative stress and act as immuno-modulators and neuroprotectants; dietary supplements, skin care products, and prescription-based hemp oil under the Kannaway and HempMeds brands; and proprietary testing, genetics, labeling and packaging, tracking, and production and standardization methods for the medicinal cannabinoid industry. In addition, it offers RSHO oil for the treatment of various illnesses and conditions; and plant-based, non-GMO pet products for health and wellness, play and wear, and environmentally-friendly supplies. Medical Marijuana, Inc. was incorporated in 2005 and is based in San Diego, California.
